Episode Details

Jason Hein, founder of Telescope Innovations (TELIF), breaks down how Telescope's robotic labs are revolutionizing biotech… the company's renowned management team and Big Pharma partnerships… and why 2026 will be a game changer for Telescope. In this episode: Welcome, Jason Hein, founder of Telescope Innovations (TELIF) [5:16] Telescope's robotic labs are revolutionizing biotech [8:27] Leveraging AI to reduce costs and improve patent timelines [14:02] Partnerships with the biggest names in Big Pharma [16:28] TELIF's management team is renowned in the scientific community [26:46] Why this year will be a game changer for Telescope Innovations [31:56] Telescope Innovations recommendation disclosure: https://www.curzioresearch.com/wp-content/uploads/2026/04/2603-Telescope-Innovations-Marketing-Disclosure.pdf Did you like this episode? Get more Wall Street Unplugged FREE each week in your inbox. Sign up here: https://curzio.me/syn_wsu Find Wall Street Unplugged podcast… --Curzio Research App: https://curzio.me/syn_app --iTunes: https://curzio.me/syn_wsu_i --Stitcher: https://curzio.me/syn_wsu_s --Website: https://curzio.me/syn_wsu_cat Follow Frank… X: https://curzio.me/syn_twt Facebook: https://curzio.me/syn_fb LinkedIn: https://curzio.me/syn_li